Investigational Drug Information for Norcocaine
✉ Email this page to a colleague
What is the development status for investigational drug Norcocaine?
Norcocaine is an investigational drug.
There have been 3 clinical trials for Norcocaine.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2010.
The most common disease conditions in clinical trials are Renal Insufficiency, Cocaine-Related Disorders, and [disabled in preview]. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Baylor College of Medicine, and Cognitive Research Corporation.
Summary for Norcocaine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 169 |
| WIPO Patent Applications | 52 |
| Japanese Patent Applications | 14 |
| Clinical Trial Progress | Phase 2 (2010-08-01) |
| Vendors | 0 |
Recent Clinical Trials for Norcocaine
| Title | Sponsor | Phase |
|---|---|---|
| PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function | Cognitive Research Corporation | Phase 1 |
| PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function | Pharmaceutical Project Solutions, Inc. | Phase 1 |
| Interactions Between Intravenous Cocaine and Acetazolamide or Quinine | National Institute on Drug Abuse (NIDA) | Phase 1 |
Clinical Trial Summary for Norcocaine
Top disease conditions for Norcocaine
Top clinical trial sponsors for Norcocaine
US Patents for Norcocaine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
